Inhalopédia | Inhalers

Class
- Inhaled corticosteroid (ICS)
Active ingredient
- Mometasone furoate
Device
- Twisthaler®
Inhalers techniques and maintenance
Age
- 4 +
Typical use
- Asthma
  Initial controller
Asthma management principles
- COPD (off-label)
  in addition to a dual bronchodilation (LAMA/LABA) when exacerbating
COPD management principles
Marketed strength
- 100 mcg
- 200 mcg
- 400 mcg
Number of doses
- 30 doses (100 and 400 mcg) | 60 doses (200 and 400 mcg)
Dose indicator
- Yes | Numerical
Usual adult dosage
- Low | 200 mcg – 1 inh QD
  Medium | 400 mcg – 1 inh QD
  High | 400 mcg – 1 inh BID
  Maximum daily dose: 800 mcg
ICS dosing
Usual pediatric dosage
- 4-5 years
  
  Not recommended
  
  6-11 years
  Low | 100 mcg – 1 inh QD
  Medium | 100 mcg – 1 inh QD
  
  12-17 years
  See adult dosage
ICS dosing
Required inspiratory flow
- > 30 - 60 L/min
  Medium-high internal resistance (R4)
Inspiratory flows
Public coverage
- 100 mcg | NL – PEI | Open/Regular Benefit
  100 mcg | AB – NS | Restricted Benefit to 4-11 years old
  100 mcg | BC – MN – NIHB – ON – PEI – QC – SK – YT | Not a benefit
  200 mcg and 400 mcg | all provinces except YT | Open/Regular Benefit
  200 mcg and 400 mcg | YT | Not a benefit
Advantages
- Impossible to take empty (locking mechanism)
- Easy handling
- Precise dose counter
- Once daily dosing (at low or medium doses)
Disadvantages
- --

Product monograph

Download

Asmanex®